Combined oral contraceptive pill for treatment of acne

College of Medicine, University College Hospital, Department of Obstetrics and Gynaecology, Ibadan, Oyo State, Nigeria.
Cochrane database of systematic reviews (Online) (Impact Factor: 6.03). 02/2007; 7(1):CD004425. DOI: 10.1002/14651858.CD004425.pub3
Source: PubMed


Acne is a common skin problem for women. Several treatments are available. Combined birth control pills, which have the hormones estrogen and progestin, are often prescribed for women with acne. This review looked at how well birth control pills worked to treat facial acne. In January 2012, we did a computer search for studies of birth control pills and acne treatment. Outcomes could be the amount of acne, how severe the acne was, and how many women dropped out early due to problems. We wrote to researchers to find other trials. We included randomized trials in any language that compared two types of birth control pills, a pill and a placebo or 'dummy,' or a pill and another acne treatment. The review now includes 31 trials with a total of 12,579 women. Ten studies used dummies. Overall, 24 pairs of treatments or placebos were compared: 6 compared a birth control pill and a placebo, 17 compared different types of birth control pills, and 1 compared a pill and an antibiotic. The six pills studied in trials with placebos worked well to reduce facial acne. When we compared pills with different hormones, we did not see any important and consistent differences. The conclusions did not change when we added trials in this update. Most trials compared two types of pills for acne treatment. Better quality studies are needed to compare one birth control pill with another. Studies should use standard methods for reporting how severe the acne is. How birth control pills compare to other acne treatments like antibiotics is not clear. Since birth control pills improve acne, they can be used to treat women with acne who also want birth control.

18 Reads
  • Source
    • "Acne vulgaris is a chronic dermatosis of the pilosebaceous follicle with four fundamental etiopathogenic factors: sebaceous hyperproduction, follicular hyperkeratinization, increase of Propionibacterium acnes colonization, and periglandular dermal inflammation [5]. Western medical treatment options generally target one or more of the factors implicated in these acne pathogeneses [6] with topical or systemic agents, phototherapy narrowband light (blue or red), and acne vaccines [7-9]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background In consideration of patients seeking to use traditional Chinese medicine, an evidence-based potentiality for safe and effective use of herbal medicine and acupuncture in treatment of acne vulgaris has been suggested. However, despite common use of a combination of herbal medicine and acupuncture in clinical practice, the current level of evidence is insufficient to draw a conclusion for an interaction and efficacy of herbal medicine and acupuncture. Therefore, considering these methodological flaws, this study was designed to assess the interaction and efficacy of an available herbal medicine, Keigai-rengyo-to extract (KRTE), and acupuncture for treatment of acne using the 2 × 2 factorial design and the feasibility of a large clinical trial. Methods/Design A randomized, assessor single blinded, 2 × 2 factorial pilot trial will be conducted. Forty four participants with acne vulgaris will be randomized into one of four groups: waiting list group (WL), KRTE only group (KO), acupuncture only group (AO), and KRTE and acupuncture combined treatment group (KA). After randomization, a total of 8 sessions of acupuncture treatment will be performed twice a week in the AO- and KA groups, respectively. Patients in the KO- and KA groups will be prescribed KRTE 3 times a day at a dose of 7.4 g after meals for 4 weeks. The following outcome measurements will be used in examination of subjects: the mean percentage change and the count change of inflammatory and non-inflammatory acne lesions, the Skindex 29, visual analogue scale (VAS) and investigator global assessment (IGA) from baseline to the end of the trial. Trial Registration The trial is registered with the Clinical Research Information Service (CRiS), Republic of Korea: KCT0000071.
    Trials 03/2011; 12(1):82. DOI:10.1186/1745-6215-12-82 · 1.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In 2002, a comprehensive methodological review of the acne literature over 50 years revealed great variation in severity assessment and outcome measures. The authors suggested a number of possible methodological improvements, since such variation makes comparisons across the literature difficult and hampers the development of evidence-based medicine in the field. To investigate whether any improvement has been achieved, we evaluated the recent literature on topical and systemic therapeutic interventions. In 18 papers, published in 2011, we identified 25 ways of reporting changes in lesion counts and 25 ways of reporting changes in assessed grade. Fourteen grading systems were used to evaluate the therapeutic response. Only three studies reported data on quality of life. Our finding reveals a continued and substantial variation in severity assessment and outcome measurement in the acne literature.
    09/2012; 1(3). DOI:10.1007/s13671-012-0016-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: Androgen hormones play an important role in common skin and hair conditions including acne vulgaris, hirsutism, and androgenetic alopecia. Blocking this androgen effect may lead to significant improvements in these conditions. Several medications that work through a variety of different mechanisms may be prescribed safely and effectively as antiandrogen therapies in the dermatology arena.
    Dermatologic Clinics 05/2006; 24(2):137-43, v. DOI:10.1016/j.det.2006.01.002 · 1.69 Impact Factor
Show more